BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22662012)

  • 1. Amphetamine use and its associated factors in body builders: a study from Tehran, Iran.
    Angoorani H; Narenjiha H; Tayyebi B; Ghassabian A; Ahmadi G; Assari S
    Arch Med Sci; 2012 May; 8(2):362-7. PubMed ID: 22662012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Misuse of Anabolic-Androgenic Steroids among Iranian Recreational Male Body-Builders and Their Related Psycho-Socio-Demographic factors.
    Angoorani H; Halabchi F
    Iran J Public Health; 2015 Dec; 44(12):1662-9. PubMed ID: 26811817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic-Androgenic Steroids and Prohibited Substances Misuse among Iranian Recreational Female Bodybuilders and its Associated Psycho-socio-demographic Factors.
    Angoorani H; Jalali M; Halabchi F
    Addict Health; 2018 Oct; 10(4):216-222. PubMed ID: 31263520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of iran.
    Nakhaee MR; Pakravan F; Nakhaee N
    Addict Health; 2013; 5(3-4):77-82. PubMed ID: 24494162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eating disorders and body image disturbances among ballet dancers, gymnasium users and body builders.
    Ravaldi C; Vannacci A; Zucchi T; Mannucci E; Cabras PL; Boldrini M; Murciano L; Rotella CM; Ricca V
    Psychopathology; 2003; 36(5):247-54. PubMed ID: 14571054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition and outcome of a curriculum to prevent disordered eating and body-shaping drug use.
    Elliot DL; Moe EL; Goldberg L; DeFrancesco CA; Durham MB; Hix-Small H
    J Sch Health; 2006 Feb; 76(2):67-73. PubMed ID: 16466469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle size satisfaction and predisposition for a health harmful practice in bodybuilders and recreational gymnasium users.
    Jankauskiene R; Kardelis K; Pajaujiene S
    Medicina (Kaunas); 2007; 43(4):338-46. PubMed ID: 17485962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization.
    Perry PJ; Lund BC; Deninger MJ; Kutscher EC; Schneider J
    Clin J Sport Med; 2005 Sep; 15(5):326-30. PubMed ID: 16162991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crisis under the radar: Illicit amphetamine use is reaching epidemic proportions and contributing to resource overutilization at a Level I trauma center.
    Gemma VA; Chapple KM; Goslar PW; Israr S; Petersen SR; Weinberg JA
    J Trauma Acute Care Surg; 2018 Nov; 85(5):953-959. PubMed ID: 30358755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids.
    Ebenbichler CF; Sturm W; Gänzer H; Bodner J; Mangweth B; Ritsch A; Sandhofer A; Lechleitner M; Föger B; Patsch JR
    Atherosclerosis; 2001 Oct; 158(2):483-90. PubMed ID: 11583730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
    Thevis M; Sauer M; Geyer H; Sigmund G; Mareck U; Schänzer W
    J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Athletes' perceptions toward substance use in Baghdad city.
    Habeeb MB; Kasim WJ; Khamees LA; Hawi MM; Khashoom QN
    Am J Mens Health; 2012 Nov; 6(6):462-71. PubMed ID: 22713800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sporting activities and psychoactive substance use. Data abstracted from the French part of the European School Survey on Alcohol and other Drugs (ESPAD 99)].
    Arvers P; Choquet M
    Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S25-34. PubMed ID: 12910031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of anabolic-androgenic steroids among body builders--frequency and attitudes.
    Lindström M; Nilsson AL; Katzman PL; Janzon L; Dymling JF
    J Intern Med; 1990 Jun; 227(6):407-11. PubMed ID: 2351927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cutaneous bacterial microflora of the bodybuilders using anabolic-androgenic steroids.
    Zomorodian K; Rahimi MJ; Taheri M; Ghanbari Asad A; Khani S; Ahrari I; Pakshir K; Khashei R
    Jundishapur J Microbiol; 2015 Jan; 8(1):e12269. PubMed ID: 25789120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illicit drug knowledge and information-seeking behaviours among elite athletes.
    Thomas JO; Dunn M; Swift W; Burns L
    J Sci Med Sport; 2011 Jul; 14(4):278-82. PubMed ID: 21377929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adolescents training and learning to avoid steroids program: preventing drug use and promoting health behaviors.
    Goldberg L; MacKinnon DP; Elliot DL; Moe EL; Clarke G; Cheong J
    Arch Pediatr Adolesc Med; 2000 Apr; 154(4):332-8. PubMed ID: 10768668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body image and steroid use in male bodybuilders.
    Blouin AG; Goldfield GS
    Int J Eat Disord; 1995 Sep; 18(2):159-65. PubMed ID: 7581418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.